This website uses technical, analytics and third party cookies. By continuing to browse, you accept our cookies.
Follow us on
AIFA has published the updated weekly data concerning treatments with new second-generation direct acting antiviral agents (DAAs) for chronic hepatitis C, as collected by AIFA Monitoring registries.
The information is contained in the page "Update on hepatitis C" accessible through the box "Related links".
Update on hepatitis C
UK’s withdrawal from the Union – Non-compliant marketing authorisations
Aggiornamento: Estensione automatica della scadenza dei certificati GMP durante la pandemia da COVID-19
Attivazione web e pubblicazione schede di monitoraggio - Registro DARZALEX